High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients
- 1 January 1996
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 49 (1) , 147-152
- https://doi.org/10.1038/ki.1996.19
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyAtherosclerosis, 1995
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995
- Vitamin Requirements for the Treatment of Hyperhomocysteinemia in HumansJournal of Nutrition, 1994
- Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemiaThe American Journal of Clinical Nutrition, 1993
- Cardiovascular Risk Factors in Chronic Renal Failure and Hemodialysis PopulationsAmerican Journal of Kidney Diseases, 1992
- Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease Effects of pyridoxine and folic acid treatmentAtherosclerosis, 1990
- Folic acid—an innocuous means to reduce plasma homocysteineScandinavian Journal of Clinical and Laboratory Investigation, 1988
- Plasma Protein-Bound Homocyst(e)ine in Patients Requiring Chronic HaemodialysisClinical Science, 1983
- Accumulation of Sulphur-Containing Amino Acids Including Cysteine-Homocysteine in Patients on Maintenance HaemodialysisClinical Science, 1980
- Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine‐homocysteine mixed disulphideEuropean Journal of Clinical Investigation, 1979